Schönnagel L, Caffard T, Vu-Han T-L, Zhu J, Nathoo I, Finos K, Camino-Willhuber G, Tani S, Guven AE, Haffer H et al..  2024.  Predicting postoperative outcomes in lumbar spinal fusion: development of a machine learning model.. Spine J. 24(2):239-249.

Woo E, Bredvik K, Liu B, Fuchs TJ, Manfredi G, Konrad C.  2023.  Machine learning approaches based on fibroblast morphometry do not predict ALS.. Neurobiol Aging. 130:80-83.

Boehm KM, Aherne EA, Ellenson L, Nikolovski I, Alghamdi M, Vázquez-García I, Zamarin D, Roche KLong, Liu Y, Patel D et al..  2022.  Multimodal data integration using machine learning improves risk stratification of high-grade serous ovarian cancer.. Nat Cancer. 3(6):723-733.

Boehm KMichael, Bhinder B, Raja VJoseph, Dephoure N, Elemento O.  2019.  Predicting peptide presentation by major histocompatibility complex class I: an improved machine learning approach to the immunopeptidome.. BMC Bioinformatics. 20(1):7.

Gareau DS, Da Rosa JCorrea, Yagerman S, Carucci JA, Gulati N, Hueto F, DeFazio JL, Suárez-Fariñas M, Marghoob A, Krueger JG.  2017.  Digital imaging biomarkers feed machine learning for melanoma screening.. Exp Dermatol. 26(7):615-618.

Konrad C, Kawamata H, Bredvik KG, Arreguin AJ, Cajamarca SA, Hupf JC, Ravits JM, Miller TM, Maragakis NJ, Hales CM et al..  2017.  Fibroblast bioenergetics to classify amyotrophic lateral sclerosis patients.. Mol Neurodegener. 12(1):76.

Perez AR, Pritykin Y, Vidigal JA, Chhangawala S, Zamparo L, Leslie CS, Ventura A.  2017.  GuideScan software for improved single and paired CRISPR guide RNA design.. Nat Biotechnol. 35(4):347-349.

Ott PA, Hu Z, Keskin DB, Shukla SA, Sun J, Bozym DJ, Zhang W, Luoma A, Giobbie-Hurder A, Peter L et al..  2017.  An immunogenic personal neoantigen vaccine for patients with melanoma.. Nature. 547(7662):217-221.